Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer

NCT00674193 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00674193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00674193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacokinetic-Pharmacodynamic-Pharmacogenetic Study of Actinomycin-D and Vincristine in Children With Cancer
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
February 29, 2008
Completion date
Not reported
Enrollment
158 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute lymphoblastic leukemia, childhood rhabdomyosarcoma, childhood soft tissue sarcoma, ewing sarcoma, ewing sarcoma of bone, ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet), unspecified childhood solid tumor, protocol specific, wilms tumor and other childhood kidney tumors